deltatrials
Completed PHASE1/PHASE2 NCT00142389

Mother's Gift Project

Comparison of Maternal and Infant Immunization Strategies to Prevent Pneumococcal Disease

Sponsor: Bill and Melinda Gates Foundation

Conditions Pneumococcal Infections
Interventions pneumococcal polysaccharide and protein conjugate vaccines
Updated 5 times since 2017 Last updated: Jun 21, 2011 Started: Aug 31, 2004 Completion: Dec 31, 2006

This PHASE1/PHASE2 trial investigates Pneumococcal Infections and is currently completed. Bill and Melinda Gates Foundation leads this study, which shows 5 recorded versions since 2004 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1_PHASE2

    First recorded

Aug 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bill and Melinda Gates Foundation
  • International Centre for Diarrhoeal Disease Research, Bangladesh
  • Johns Hopkins Bloomberg School of Public Health
  • Thrasher Research Fund
  • United States Agency for International Development (USAID)
  • Wyeth is now a wholly owned subsidiary of Pfizer
Data source: Johns Hopkins Bloomberg School of Public Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Dhaka, Bangladesh